StreetAlpha.app
Home › Stocks › NYXH

Nyxoah SA (NYXH)

$0.88
▼ −1.10%
LAST CLOSE · NOV 17

Nyxoah makes the Genio system, an implant that treats obstructive sleep apnea by stimulating the hypoglossal nerve. It last closed at $0.88 on Nov 17, down 1.10% on the day.

AI Auto Pilots
Is NYXH in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−EUR 90.1M
Free cash flow
−EUR 69.8M
Balance sheet
Cash & equivalents
EUR 30.0M
At Dec 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −EUR 27.6M−EUR 27.6MFY2021FY2022: −EUR 31.2M−EUR 31.2MFY2022FY2023: −EUR 43.2M−EUR 43.2MFY2023FY2024: −EUR 59.2M−EUR 59.2MFY2024FY2025: −EUR 90.1M−EUR 90.1MFY2025

From NYXH's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 26). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated NYXH in the past 90 days, not enough for a consensus
Average 12-month target
$3.00
▲ 239.4% upside

Based on 1 analyst who set a price target on NYXH in the past 90 days. The average target is $3.00, with a high of $3.00 and a low of $3.00, compared with the last close of $0.88.

Low $3.00Avg $3.00High $3.00
Blue marker: last close $0.88
Highest target$3.00
Average target$3.00
Lowest target$3.00
Latest rating changes
Cantor FitzgeraldTarget lowered
Oct 27Buy$6 → $3
Cantor FitzgeraldMaintained
Aug 17Buy$6
Piper SandlerReiterated
Aug 6Buy$6
StifelTarget lowered
Jun 17Hold$5 → $3
StifelDowngrade
May 12Hold$5
DateFirmActionRatingPrice target
Oct 27Cantor FitzgeraldTarget loweredBuy$6 → $3
Aug 17Cantor FitzgeraldMaintainedBuy$6
Aug 6Piper SandlerReiteratedBuy$6
Jun 17StifelTarget loweredHold$5 → $3
May 12StifelDowngradeHold$5
Loading…

Technical Analysis

NYXH · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock sits between its 20 and 50 day averages. It is 156% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 37), near oversold. The nearest support is the 20 day average at $0.88, and the nearest resistance the Pivot at $0.89.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNear oversold
VolatilityNormal, 5.9%/day
Key levels
$5.3952 week high+512.5%
$2.26200 day average+156.8%
$1.37100 day average+55.7%
$1.1750 day average+33.0%
$0.91Swing high (Nov 9)+3.4%
$0.89Pivot R1+1.1%
$0.89Pivot+1.1%
$0.8820 day average+0.0%
$0.88Pivot S1+0.0%
$0.88Last close
$0.8052 week low−9.1%
$0.80Swing low (Nov 5)−9.1%
Indicators
RSI (14)37.37Weak, oversold below 30Neutral
MACD-0.08Above its signal lineBullish
Stochastic58.4Middle of its rangeNeutral
ADX (14)30.7Trending down
Williams %R-35.7Oversold below −80, overbought above −20Neutral
CCI (20)20.7Oversold below −100, overbought above 100Neutral
Rate of change−1.5%Change over 10 sessionsBearish
ATR (14)$0.05Typical daily range, 5.9% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
What happened before, for NYXH

What happened before

See how NYXH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow NYXH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How NYXH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in NYXH in the last 90 days.

Loading…

See today’s whale options flow across the market →

NYXH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●20 buying vs 18 selling
  • ▼Shares held by funds -11.7%
  • ▼Funds holding -8
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding3745−17.8%
In funds' top 10110.0%
Held by funds–––
New / increased7 / 1319 / 6−20.0%
Reduced / sold out5 / 133 / 8+63.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NYXH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NYXH is in one of them and how their past NYXH trades turned out.

NYXH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NYXH in an article yet. Here's the latest on the wider market.

About Nyxoah SA

Nyxoah develops and sells the Genio system, a medical device for treating obstructive sleep apnea, a condition in which the airway repeatedly becomes blocked during sleep. The Genio system is an implant placed through a single incision under the chin that provides bilateral stimulation of the hypoglossal nerve to help keep the airway open. It is intended for adults with moderate to severe sleep apnea who cannot tolerate or adhere to CPAP, the standard mask-based therapy. The company sells to hospitals and sleep physicians in Europe and the United States and is based in Mont-Saint-Guibert.

Headquarters
Mont-Saint-Guibert